{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:49:22Z","timestamp":1761518962202},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Current Medical Science"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1007\/bf02873575","type":"journal-article","created":{"date-parts":[[2010,6,22]],"date-time":"2010-06-22T20:35:12Z","timestamp":1277238912000},"page":"194-197","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effects of metformin combined with cyproterone acetate on clinical features, endocrine and metabolism of non-obese women with polycystic ovarian syndrome"],"prefix":"10.1007","volume":"25","author":[{"given":"Lv","family":"Liqun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun","family":"Yongyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tan","family":"Kan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,4,1]]},"reference":[{"key":"BF02873575_CR1","first-page":"3078","volume":"83","author":"ES Knochenhauer","year":"1998","unstructured":"Knochenhauer ES, Key TJ, Kahsar-Miller Met al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab, 1998, 83:3078","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02873575_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0015-0282(99)00497-5","volume":"73","author":"B Hacihanefioglu","year":"2000","unstructured":"Hacihanefioglu B, Seyisoglu H, Karsidag Ket al. Influence of insulin resistance on total rennin level in normotensive women with polycystic ovary syndrome. Fertil Steril, 2000, 73:261","journal-title":"Fertil Steril"},{"key":"BF02873575_CR3","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0889-8545(05)70157-1","volume":"27","author":"A E Tavior","year":"2000","unstructured":"Tavior A E. Insulin-lowering medications in polycystic ovary syndrome. Obstet Gynecol Cim North Am, 2000, 27:583","journal-title":"Obstet Gynecol Cim North Am"},{"key":"BF02873575_CR4","first-page":"3327","volume":"80","author":"M T Korytkowski","year":"1995","unstructured":"Korytkowski M T, Mokan M, Horwitz M Jet al. Metabolic effects of oral contraceptives in women with polycystic ovary syndrome. J Clin Endocrinol Metab, 1995, 80:3327","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02873575_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0015-0282(16)57728-0","volume":"64","author":"Y Robert","year":"1995","unstructured":"Robert Y, Dubrulle F, Gaillandre L et al. Ultrasound assessment of ovarian stroma hypertrophy in hyperan-drogenism and ovulation disorders: visual analysis versus computerized quantification. Fertil Steril, 1995, 64:307","journal-title":"Fertil Steril"},{"issue":"10","key":"BF02873575_CR6","first-page":"774","volume":"18","author":"A Dunaif","year":"1997","unstructured":"Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesia. Endocr Rev, 1997, 18(10):774","journal-title":"Endocr Rev"},{"key":"BF02873575_CR7","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1056\/NEJM199602293340906","volume":"334","author":"C J Bailyey","year":"1996","unstructured":"Bailyey C J, Turner R C. Metformin drug therapy. N Engl J Med, 1996, 334:574","journal-title":"N Engl J Med"},{"key":"BF02873575_CR8","first-page":"139","volume":"85","author":"P Moghetti","year":"2000","unstructured":"Moghetti P, Castello R, Negri Cet al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab, 2000, 85:139","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02873575_CR9","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0015-0282(98)00011-9","volume":"69","author":"L C Morin-Papunen","year":"1998","unstructured":"Morin-Papunen L C, Koivunen R M, Ruokonen Aet al. Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome. Fertil Steril, 1998, 69:691","journal-title":"Fertil Steril"},{"key":"BF02873575_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/humrep\/15.1.21","volume":"15","author":"A Ia Marca","year":"2000","unstructured":"Ia Marca A, Egbe T O, Morgante Get al. Metformin treatment reduces ovarian cytochrome P-450c17alpha response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome. Hum Reprod, 2000, 15:21","journal-title":"Hum Reprod"},{"key":"BF02873575_CR11","first-page":"4075","volume":"82","author":"J E Nestler","year":"1997","unstructured":"Nestler J E, Jakubowicz D J. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. J Clin Endocrinol Metab, 1997, 82:4075","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02873575_CR12","first-page":"3161","volume":"85","author":"L C Morin-Papunen","year":"2000","unstructured":"Morin-Papunen L C, Vauhkonen L, Koivunen R Met al. Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study. J Clin Endocrind Metab, 2000, 85:3161","journal-title":"J Clin Endocrind Metab"},{"key":"BF02873575_CR13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0015-0282(01)01975-6","volume":"76","author":"G R Attia","year":"2001","unstructured":"Attia G R, Rainey W E, Carr B R. Metformin directly inhibits androgen production in human thecal cells. Fertil Steril, 2001, 76:517","journal-title":"Fertil Steril"},{"key":"BF02873575_CR14","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1093\/humrep\/13.10.2706","volume":"13","author":"E Dahlgren","year":"1998","unstructured":"Dahlgren E, Landin K, Krotkiewski Met al. Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome. Hum Reprod, 1998, 13:2706","journal-title":"Hum Reprod"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02873575.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02873575\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02873575","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02873575.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T05:37:32Z","timestamp":1706852252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02873575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["BF02873575"],"URL":"https:\/\/doi.org\/10.1007\/bf02873575","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"20 September 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2005","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}